Concepedia

Elderly Patients with Advanced NSCLC in Phase III Clinical Trials: Are the Elderly Excluded from Practice-Changing Trials in Advanced NSCLC?

Adrian G. Sacher, Lisa W. Le, Natasha B. Leighl, Linda Coate

Journal of Thoracic Oncology · 2013 · 108 citations · 12 references

DOIFull text

Open access

Concepts

References

12

Cancer statistics, 2012

Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text

, , +16

Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials

Laura F. Hutchins, Joseph M. Unger, John J. Crowley et al. · New England Journal of Medicine · 1999 · 2.2K citations

, , +13

Longitudinal Studies on the Rate of Decline in Renal Function with Age

Robert D. Lindeman, Jordan Tobin, N. W. Shock · Journal of the American Geriatrics Society · 1985 · 1.6K citations

, , +17

Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials

Joy H. Lewis, Meredith L. Kilgore, Dana P. Goldman et al. · Journal of Clinical Oncology · 2003 · 1K citations

, , +15

Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial

Élisabeth Quoix, Gérard Zalcman, Jean-Philippe Oster et al. · The Lancet · 2011 · 575 citations

, , +10